Confluent Medical Technologies closes majority investment from TPG Capital

Confluent Medical Technologies announced that it closed a majority investment from TPG Capital following TPG’s agreement to acquire a majority stake in the company.

Last month, Confluent Medical confirmed that TPG Capital signed a definitive agreement to acquire a majority stake in the company, joining existing investor Ampersand Capital Partners, which retains a substantial minority interest, according to a news release.

Confluent develops and manufactures Nitinol-based medical components and specializes in prototyping designing, developing and manufacturing implants, delivery systems and other components for neurovascular, electrophysiology, structural heart, peripheral vascular and minimally invasive procedures.

The company touted the closing of the investment as the latest step forward in a period of momentum, having developed film cast capabilities for PTFE liners and polyimide tubing, invested into electrospinning capabilities and expanded in…

Read more
  • 0

TPG Capital makes majority investment in Confluent Medical Technologies

Confluent Medical Technologies announced today that TPG Capital agreed to make a majority investment in the company.

TPG Capital joins Amerpand Capital Partners, an existing investor that will retain a substantial minority interest in Confluent, according to a news release.

Scottsdale, Arizona-based Confluent partners OEMs to support the design, development and manufacturing of life-saving implants, minimally invasive delivery systems and other medical devices.

“Confluent’s depth of expertise in Nitinol processing and other complex modalities, differentiated manufacturing capabilities and unique end-to-end integration have positioned the company as a trusted design and manufacturing partner to OEMs for many of the most complex implantable products,” TPG Capital Partner Kendall Garrison said in the release.

J.P. Morgan Securities LLC acted as the exclusive financial advisor and Goodwin Procter LLP served as the legal counsel to Confluent in this tr…

Read more
  • 0